Entropy Technologies’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.3M Buy
11,052
+2
+0% +$2.04K 0.53% 32
2026
Q1
$10.2M Buy
+11,050
New +$11.2M 0.47% 53
2025
Q3
Sell
-1,503
Closed -$1.17M 968
2025
Q2
$1.17M Buy
+1,503
New +$1.17M 0.09% 273
2025
Q1
Sell
-8,141
Closed -$6.28M 858
2024
Q4
$6.28M Buy
8,141
+4,329
+114% +$3.58M 0.65% 20
2024
Q3
$3.38M Sell
3,812
-224
-6% -$201K 0.35% 77
2024
Q2
$3.65M Buy
+4,036
New +$3.23M 0.39% 66

Other funds holding LLY

Entropy Technologies's LLY Position: Q2 2026 in Review

Entropy Technologies increased its Eli Lilly (LLY) stake by 0.02% in Q2 2026, buying an estimated $2.04K and bringing the position to 11,052 shares worth $13.3M. The position accounts for 0.53% of the portfolio, ranked #32.

Entropy Technologies first reported a position in LLY in Q2 2024 and has held it in 6 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Entropy Technologies held 11,052 shares of Eli Lilly worth $13.3M as of Q2 2026.
  • Entropy Technologies bought 2 Eli Lilly shares in Q2 2026, an estimated $2.04K.
  • Eli Lilly made up 0.53% of Entropy Technologies's portfolio in Q2 2026, its #32 holding.
  • Entropy Technologies first reported a position in Eli Lilly in Q2 2024 and has held it in 6 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.